(G) HyPer-cyto fluorescence lifetimes in 18 H 2 O 2 cells before and after H 2 O 2 treatment, with recovery and re-stimulation, relative to untreated cell mean set to 0 (dashed line). Upper and lower quartiles define box with median line, 5-95% range whiskers. One-way ANOVA followed by Tukey's post hoc, ***p<0.001. (H) Wound closure quantification at 24 h at varying NAC concentrations. (Mean + SEM, n = 3. One-way ANOVA followed by Tukey's post hoc, ***p<0.001, **p<0.01).
H 2 O 2 detection using HyPer fluorescent probes
To detect H 2 O 2 in cells, we used the fluorescent probe HyPer that specifically detects H 2 O 2 due to a conformational change resulting from disulfide bond formation [S1] that can be measured by fluorescence lifetime imaging microscopy (FLIM) [S2], which has the advantage of independence from fluorophore concentration. As HyPer localizes throughout the cytoplasm (HyPer-cyto), a plasma-membrane targeted form was also made (HyPer-PM) by adding a carboxyl-terminal CAAX-prenylation motif 
Reactive oxygen scavenging reduces cell migration
To determine if elevated H 2 O 2 was required for 2-dimensional migration induced by scratch wounding, cells were treated with N-acetylcysteine (NAC), which significantly decreased cellular ROS as measured by the cell permeable reagent 2',7'dichlorofluorescin diacetate ( Figure S2F ). NAC-treated cell migration in a 96-well kinetic assay, in which migration into a wound created through a confluent monolayer was measured, revealed a concentration dependent decrease in wound closure after 24 h ( Figures S2G and S2H ), paralleling the reduced ROS levels observed with equivalent NAC concentrations ( Figure S2F ). (Mean + SEM, n = 12-15. One-way ANOVA followed by Tukey's post hoc, ***p<0.001, ns = not significant). 3-13. One-way ANOVA followed by Tukey's post hoc, **p<0.01, ns = not significant).
Cofilin oxidation inhibits activity
To characterize the effect of cofilin oxidation on F-actin binding, we first confirmed in vitro oxidation of recombinant cofilin with increasing H 2 O 2 concentrations by labelling non-oxidized thiols with biotin-iodoacetamide (biotin-IAA) and measuring incorporation with fluorescent streptavidin. Biotin-IAA labeling of non-oxidized cofilin (CFL) decreased with increased H 2 O 2 ( Figure S3E ).
Cofilin activity was also measured using a pyrene-conjugated actin assay that reports on 2 cofilin activities: (1) regulation of F-actin levels [S4], which reflects filament severing, depolymerization and polymerization equilibrium; (2) cofilin binding to F-actin due to the possibility of cofilin-mediated quenching of pyrene fluorescence.
Cofilin oxidation, as determined by decreased biotin-IAA labeling of non-oxidized cofilin ( Figure S3E ), paralleled the reduction in cofilin activity in the pyrene-actin assay ( Figures S3F and S3G ). To identify cysteine residues sensitive to H 2 O 2 , we assayed C39A, C80A, C139A and C147A cofilin. Following oxidation with 10 mM 
Supplemental Experimental Procedures
Cell Culture MDAMB231 breast cancer cells were grown in DMEM (Gibco) supplemented with 10% fetal bovine serum (FBS) (PAA), 2 mM L-glutamine (Gibco), 10 U/ml penicillin and 10 µg/ml streptomycin (Gibco) and kept at 37 o C with 5% CO 2 in a humidified incubator. MDAMB231 cell lines stably expressing HyPer-cyto, HyPer-PM, Cherry, Ch-CFL, Ch-CFL(C139A), Ch-CFL(C147A) or Ch-CFL(AA) were grown and maintained as described above with the exception that the culture medium was also supplemented with 400 µg/ml G418 (Formedium).
Plasmid construction
pHyPer-cyto was purchased from Evrogen. pHyPer-PM was constructed by introducing a C-terminal CAAX motif (5'-AGC TTA AAA AGA TGA GCA AGG ACG GCA AGA AGA AGA AGA AGA AGA GCA AGA CAA AGT GTG TAA TTA TGT AAG -3') to the pHyPer-cyto plasmid. Plasmids for the expression of CFL Cys to Ala mutants (C39A, C80A, C139A, C147A and C139/147A) were generated from the pGEX-KG-hCFL WT plasmid [S5] by site directed mutagenesis using the QuikChange II XL Site-Directed Mutagenesis Kit (Agilent Technologies) following the manufacturer's protocol. Mutations were introduced using the following forward, and corresponding reverse, primers; C39A (5'-CGC AAG AAG GCG GTG CTC TTC GCG CTG AGT GAG GAC AAG -3'), C80A (5'-GCT GCC AGA TAA GGA CGC GCG CTA TGC CCT CTA TGA TGC AAC C -3'), C139A (5'-GAA TTG CAA GCA AAC GCG TAC GAG GAG GTC AAG GAC CGC -3'), C147A (5'-GAG GAG GTC AAG GAC CGC GCG ACC CTG GCA GAG AAG -3'), C139D/C147D (5'-GAA TTG CAA GCA AAC GAC TAC GAG GAG GTC AAG GAC CGC GAC ACC CTG GCA GAG AAG -3'). Ch-CFL plasmid was generated by amplifying the CFL from pGEX-KG-hCFL WT and cloning it into pmCherry-C1 plasmid. Ch-CFL(AA), Ch-CFL(C139A) and Ch-CFL(C147A) were created by site directed mutagenesis as above using the C139A and C147A primers.
Generation of stable cell lines
MDAMB231 cells were transfected with HyPer-cyto or HyPer-PM plasmids using FuGENE HD transfection reagent (Promega), or Cherry, Ch-CFL, Ch-CFL(AA), Ch-CFL(C139A) or Ch-CFL(147A) plasmids using Lipofectamine LTX transfection reagent (Invitrogen) following the manufacturers' protocols. 48 h after transfection cells were selected in culture medium containing 400 µg/ml G418, followed by enrichment by flow cytometry on a FACSaria (BD Bioscience).
Measurement of cellular ROS
Cellular ROS levels were measured using the fluorescent probe DCFDA. MDAMB231 cells were seeded at 40,000 cells per well in a 96-well plate and 24 h later were treated with NAC (0, 2.5, 5 or 10 mM) for 6 h. Cells were washed once with PBS before incubation with 5 µM DCFDA in serum free (SF) and phenol red free DMEM at 37 o C for 30 min. Following a PBS wash and the addition of SF and phenol red free medium, DCFDA fluorescence was measured on a Tecan Safire II microplate reader (excitation wavelength = 485 nm; emission wavelength = 528 nm; bandwidth = 5 nm). Cells were then left for 1 h before being transferred to L15 medium for imaging.
HyPer imaging by FLIM

Wound healing cell migration assay
Cell migration was assessed using the CellPlayer TM 96-well cell migration assay (Essen Bioscience) following the manufacturer's protocol. Briefly, cells were cultured in a 96-well ImageLock TM plate until they formed a confluent monolayer and then a wound created using a WoundMaker TM tool. Cells were washed twice with medium followed by the addition of NAC (0, 2.5, 5 or 10 mM), the plate placed in the Incucyte TM machine to equilibrate for 10 min before starting image acquisition.
Brightfield images of the wounds were taken every 2 h for 24 h and wound width at each time point measured by the Incucyte TM software.
Measurement of cellular protein oxidation
Oxidized proteins in cells were labelled and detected using the chemical dimedone.
Cells were cultured in 6-well dishes to form a confluent monolayer and then 30 wounds generated using a P10 pipette tip. After 3 h cell culture medium was removed, cells washed twice with SF culture medium and incubated in SF culture medium containing 5 mM dimedone at 37 o C for 1 h. Cells were then harvested and dimedone labelling of oxidized proteins determined by western blot analysis.
Protein preparation and western blotting
Cells were lysed using RIPA lysis buffer (10 mM Tris-HCl pH 7.5, 5 mM EDTA, 150 mM NaCl, 40 mM Na pyrophosphate, 1 mM Na 3 VO 4 , 50 mM NaF, 1% NP40, 0.5% Na deoxycholate, 0.025% SDS, 1 mM PMSF, 1X complete protease inhibitor) and protein concentration determined by bicinchoninic acid assay. For western blotting proteins were separated by SDS-PAGE on 4-12% NuPAGE Bis-tris gels with NuPAGE MES running buffer (Invitrogen) and transferred to Protran nitrocellulose membrane (GE Healthcare). Membranes were blocked with 5% milk solution (w/v) and probed with antibodies to cofilin (Abcam ab42824, 1:1,000 ; Abcam ab75510, 1:2,000), dsRed (Clontech 632496, 1:1,000), dimedone (cysteine sulfenic acid) (Millipore 07-2139, 1:5,000) or GFP (Clontech 632380, 1:2,000). Visualization and quantification of Western blots was performed directly without signal amplification or X-ray film using infra-red emitting secondary antibodies and detection with an ODYSSEY ® infrared imaging system (LI-COR).
Immunoprecipitation
At every stage protein G Sepharose beads were separated from the supernatant by centrifuging at 3,600 rpm for 1 min at 4 o C. Cells were washed with ice cold PBS, 
Recombinant protein production
Overnight cultures of pGEX-KG-hCFL WT, pGEX-KG-hCFL C39A, pGEX-KG-hCFL C80A, pGEX-KG-hCFL C139A, pGEX-KG-hCFL C147A or pGEX-KG-hCFL C139/147A in E. coli BL21 (DE3) pLys s cells were diluted 1:10 in L-broth containing 150 µg/ml ampicillin and grown in a shaking incubator at 37 o C until the OD 600 was between 0.6 and 1.0. Cultures were induced with 100 µM IPTG and grown for a further 3 h in the shaking incubator at 37 o C. Protein expression from pGEX-KG-hCFL C139D/C147D was induced with 100 µM IPTG for ~20 h at 18 o C. Cells were pelleted by centrifuging at 4,000 rpm for 20 min at 4 C, resuspended in bacterial lysis buffer (1x TBS, 2x complete protease inhibitor, 3 mM DTT, 1 mg/ml lysozyme), lysates incubated on ice for 30 min, sonicated and then centrifuged at 14,000 rpm for 30 min at 4 o C. The supernatant was incubated overnight at 4 C with TBS-washed glutathione sepharose beads (GE Healthcare). Beads were washed with wash buffer 1 (1x TBS, 3 mM DTT, 1 mM EDTA) followed by wash buffer 2 (1x TBS, 1 mM MgCl 2 , 1 mM CaCl 2 , 3 mM DTT). CFL proteins were released from the GST tag by incubation with 50 U bovine thrombin (Sigma) overnight at 4 o C. Flow-through was collected, incubated with TBS-washed ρ-aminobenzamidine bead solution (50% v/v), for 30 min at 4 o C while rotating and the supernatant containing the protein was collected, concentrated and aliquots stored at -80 o C.
Oxidation of recombinant CFL
CFL was dialyzed to remove DTT from storage buffer and concentrated to 12.5 µg/µl. 50 µg of CFL was incubated with 20 µl of H 2 O 2 at the indicated concentrations (up to 10 mM) for 1 h on ice in the dark. Remaining H 2 O 2 was quenched by the addition of catalase.
Labelling of recombinant CFL
Oxidation of recombinant CFL was monitored by labelling with biotin-iodoacetamide (IAA). 1 nmole of biotin-IAA was incubated with recombinant CFL for 20 min in the dark at room temperature. Remaining biotin-IAA was quenched by the addition of βmercaptoethanol to a final concentration of 30 mM and biotin-IAA labelling of CFL assessed by SDS-PAGE and western blotting using Alexa Fluor 680-conjugated streptavidin.
In vitro cofilin activity assay
G-actin was purified from rabbit skeletal muscle as described previously [S6] and maintained in G-buffer (2 mM Tris-HCl pH 8.0, 0.2 mM ATP, 0.5 mM DTT, 0.2 mM CaCl 2 ) [S5] . 1 mg/ml G-actin was labeled with 5 mg/ml pyrene in dimethylformamide for 15 h and dialyzed in G-buffer. Actin polymerization was initiated by the addition of 50 mM KCl, 2 mM MgCl 2 , and 0.1 mM EGTA, and then ultracentrifuged to pellet the F-actin. The F-actin pellet resuspended in G-buffer and concentration determined. 2 µM F-actin was prepared by polymerizing 2 µM G-actin (95% unlabelled; 5% labelled) at room temperature for 2-3 h until steady state fluorescence (excitation = 339 nm; emission = 384 nm), as measured on a spectrofluorimeter, was reached. 50 µl of F-actin was added to a PTI glass cuvette, with or without 10 µM WT or mutant CFL, and fluorescence measured for 300 s. Data were presented as change in fluorescence over time.
F-actin sedimentation assay
The Actin Binding Protein Biochem Kit with Non-Muscle Actin (Cytoskeleton) was used according to manufacturer's instructions. Aliquots of actin polymerization buffer and ATP were rapidly defrosted in a room temperature water bath and kept on ice.
Cofilin1 samples were centrifuged for 1 h at 100,000 X g at 4 ° C, supernatants taken and kept on ice as test protein stocks. General actin buffer was supplemented with 0.2 mM final ATP. One 250 μg aliquot of actin was diluted to 1 mg/ml with 225 μl of ATP-supplemented general actin buffer, mixed to ensure complete re-suspension and left on ice for 30 min. 25 μl of actin polymerization buffer was pipetted into the actin protein and mixed well. The actin was incubated at room temperature for 1 h and kept as F-actin stock at 21 μM actin. All tubes were incubated at room temperature for 30 min, with untreated or H 2 O 2 treated cofilin at 10 μM added as indicated. Afterwards the tubes were centrifuged at 100,000 X g for 1.5 h at 24 °C.
Supernatants were removed and kept on ice. To each tube 10 μl of 5× Laemmli reducing sample buffer was added. The pellets were re-suspended in 30 μl water by mixing for 2 min, leaving on ice for 10 min and repeated mixing. The samples were transferred into tubes and supplemented with 30 μl 2× Laemmli reducing-sample buffer. The samples were frozen at −20 °C until further analysis by SDS-PAGE.
Quantification was performed with a Licor Odyssey by scanning the fluorescence intensity of SimplyBlue (Invitrogen) stained bands at 700 nm.
In vitro F-actin severing assay
Actin severing assay was performed as described in [S7] . A mixture of monomeric unlabelled (1.4 µM), rhodamine-conjugated (0.4 µM) and biotin-conjugated (0.2 µM) muscle actin (Cytoskeleton) in General Actin Buffer (Cytoskeleton) was supplemented with 0.2 mM ATP according to manufacturer's instructions. Actin Polymerization Buffer (Cytoskeleton) was added at 10% volume/volume and the mixture incubated at room temperature for 2 h to make an F-actin stock that could be stored at 4°C for up to 4 days. To affix to F-actin streptavidin-coated coverslips (PolyAn GmbH), 5 µl of ISAP buffer (20 mM Tris pH 7.2, 5 mM EGTA, 2 mM MgCl 2 , and then removed. F-actin (5 µl) was then placed onto the spot, left for 30 minutes, and then washed 3 times with 5 µl of 20 mM Tris pH8, 50 mm NaCl. Next, 5 µl of 20 mM Tris pH8, 50 mM NaCl buffer with no addition, 1 µM untreated cofilin or 1 µM cofilin that had been pretreated with 10 mM H 2 O 2 was added, left for 30 minutes and then washed 3 times with 5 µl anti-bleach buffer (20 mM Tris pH 7.2, 5 mM EGTA, 2 mM MgCl 2 , 50 mM KCl, 1 mM ATP 1 mM DTT, 5 mg/ml BSA, 0.036 mg/ml catalase, 6 mg/ml glucose, 0.02 mg/ml glucose oxidase). After the last wash, liquid was removed and the coverslip was sealed onto a glass slide with nail varnish and kept in the dark at 4°C. Images were acquired with an Olympus BX51 fluorescence microscope using a 100X oil-immersion objective at 1-2 sec exposures.
For analysis of actin filament lengths, a macro was written for ImageJ in which the user selects a directory containing all the images for a certain condition and it processes each image in turn and saves the results automatically. Upon loading of each image, a duplicate was made and used for creation of a mask. Removal of uneven illumination artefacts was achieved by using the default ImageJ 'Background subtraction' method with the sliding parabola model and a radius of 16 pixels. The image was then automatically thresholded using a minimum value of: min = mean + standard deviation, and max = maximum/3, to produce a mask that was then applied to the original image. This process removed the background noise bias introduced in the Gray-Level Co-occurrence Matrix (GLCM) analysis by selecting only the fluorescent signal. The masked image was then passed to the GLCM texture plugin, which had been modified so that it could be operated in a nested loop for varying pixel comparison distances and alternative directions of comparison. The output of the plugin for each image was 100 rows of the five texture parameters over each of four directions, so in total 2000 parameter values. These were saved as a text data file for each image. When all the images in the directory were analysed, the data files were processed using a Matlab script that eventually gave the mean of each texture parameter for each image. These were then imported into GraphPad Prism for plotting.
Thermal shift assay
A protein thermal fluorescence assay was undertaken to assess cofilin stability, using the Protein Thermal Shift kit (Life Technologies) according to manufacturer's instructions. Briefly, 5 μl of Protein Thermal Shift Buffer was mixed with 2.5 μl Protein Thermal Shift Dye (8x) and 12.5 μl protein. The protein melting was performed on a Applied Biosystems 7500 FAST Real-Time PCR system, on a curve from 25 °C to 95°C . All measurements were done in quadruplicate.
Cell adhesion/spreading assay
Kinetics of cell adhesion and spreading were measured using the xCelligence Real-Time Cell Analyzer (RTCA) system (Roche). 10,000 cells were plated in an E-plate 16 and placed in the RTCA in a humidified incubator at 37 o C with 5% CO 2 . Cell index was measured every 10 min for 3 h.
Cell adhesion assay
50 µl of culture medium was added to each well of a 96-well tissue culture plate and incubated in standard culture conditions for 1 h. 40,000 cells in 100 µl culture medium were plated in each well and left for 3 h in standard culture conditions. Wells were washed 4 times with PBS to remove non-adherent cells and the number of adherent cells measured using the CellTiter Glo Luminescent Cell Viability Assay following the manufacturer's protocol.
Cell directionality assay
Cells were seeded at a subconfluent density in a 6-well tissue culture plate and placed on a Nikon TE 2000 Timelapse microscope fitted with an incubation chamber set at 37 o C with 5% CO 2 . Cells were left for 1 h to allow the cells to settle and for the plasticware to equilibrate. Brightfield images were acquired every 10 min for 4 h with a 10x objective. Migration of 8-12 individual cells per well was analyzed in ImageJ using the manual tracking and chemotaxis tool plugins.
Force indentation acquisition
Mechanical properties of individual cells were measured using an atomic force microscope NanoWizard II (JPK Instruments) mounted on an inverted optical microscope, Zeiss Axio Observe with a cell heater attachment. Force indentation measurements were carried out using in-house prepared AFM colloidal probes (~5 µm spherical silica bead cantilevers, with a typical spring constant of ~0.02 N/m) as described previously [S8] . Calibration measurements were performed before every experiment to determine the spring constant for each cantilever as described in reference [S9]. Cells were cultured overnight prior to force indentation measurements. Five consecutive force (1 nN) indentations were applied over the nucleus of each cell. The Hertzian spherical model was applied to the force spectroscopy data to deduce the elastic modulus of the cell structure [S10] .
3D modelling of cofilin-actin interface
The model of cofilin and actin was created based on the crystal structure of the CFL (PDB ID: 4BEX) [S11] , and the crystallized complex of G-actin and the C-terminal domain of twinfilin (PDB ID: 3DAW) [S12]. Charges and radii of the atoms in the structure were calculated using PDB2PQR [S13] , except for the charges and radii of the oxidized cysteines which were calculated using a developmental version of PRODRG [S14] . Electrostatic surface potentials were calculated using APBS [S15] . 
Isothermal titration calorimetry
Isothermal titration calorimetry experiments were performed at 25 °C in a Microcal iTC 200 (GE Healthcare). Cofilin and actin were dialysed against 10 mM Tris pH 7.6, 0.2 mM CaCl 2 , 0.2 mM ATP, 2 mM β-mercaptoethanol. The sample cell was filled with G-actin at a concentration of 30 μM, and titrated against Cofilin in the syringe at a concentration of 1.2 mM. 2 μl injections were done every 180 seconds.
Controls were performed by injecting cofilin into buffer, or buffer into G-actin. Data were analysed using the ORIGIN software, version 7.0.
Mass spectrometry
The protein lysate was digested using the filtered aided sample preparation (FASP) protocol [S16] with minor adjustments. Briefly, the protein was digested in spin ultrafiltration units with a nominal molecular weight "cut-off" of 30,000 Da. Lysate containing ~500 µg of protein was taken and diluted with 200 µL of 8 M urea in 0.1 M Tris/HCl, pH 8.5 (UA). The sample was centrifuged at 14 000 × g at 20°C for 15 min.
The filter was then washed with an addition of 200 µL UA and centrifuged as before. 100 µL of 0.05 M iodoacetamide in UA was added to the filter and the sample was incubated in darkness for 20 min at room temperature. The filter was washed twice with 100 µL of UA followed by two washes with 100 µL 50 mM ammonium bicarbonate. Proteins were digested in 40 µL 50 mM ammonium bicarbonate using trypsin at enzyme to protein ratio 1:100 at 30°C for 18 h. The released peptides were collected by centrifugation at 14 000 × g for 10 min followed by one wash with 50 µL 50 mM ammonium bicarbonate.
The peptides were fractionated using a high pH reverse phase liquid chromatography strategy in a similar approach as Ding et al. [S17] . The separation was performed using a Durashell RP column (5 µm, 150 Å, 250 mm × 4.6 mm i.d.).
Mobile phases A (2% acetonitrile, adjusted pH to 10.0 using NH3•H20) and B (98% acetonitrile, adjusted pH to 10.0 using NH3•H20) were used to develop a gradient.
The solvent gradient was set as follows: 4% B, 6 min; 4%-28% B, 42 min; 28%-50% B, 50 min. The peptides were separated at an eluent flow rate of 1.0 mL/min and monitored at 220 nm. Fractions were collected every 1.5 min. The first five and last five were pooled and dried under vacuum along with the other fractions.
